Synthetic oligodeoxynucleotides containing CpG motifs enhance immunogenicity of a peptide malaria vaccine in Aotus monkeys

Vaccine

Volumn 17, Issue 23-24, 1999, Pages 3065-3071

  Jones, Trevor R ^a   Obaldia III, Nicanor ^b   Gramzinski, Robert A ^a   Charoenvit, Yupin ^a   Kolodny, Nelly ^c   Kitov, Svetlana ^c   Davis, Heather L ^d,e   Krieg, Arthur M ^e,f   Hoffman, Stephen L ^a  

^a NAVAL MEDICAL RESEARCH CENTER   (United States)

^b Promed Trading   (Panama)

^c WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^d OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^e PFIZER INC   (United States)

^f UNIVERSITY OF IOWA   (United States)

Author keywords

Aotus; CpG motif; Immunization; Malaria; Oligodeoxynucleotide

Indexed keywords

MALARIA VACCINE; OLIGONUCLEOTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ARTICLE; DRUG FORMULATION; IMMUNIZATION; IMMUNOGENICITY; MALARIA; MONKEY; NONHUMAN; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL;

ADJUVANTS, IMMUNOLOGIC; AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, PROTOZOAN; AOTIDAE; CPG ISLANDS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; MALARIA VACCINES; MALE; MOLECULAR SEQUENCE DATA; OLIGONUCLEOTIDES; PEPTIDES; PLASMODIUM FALCIPARUM; PROTOZOAN PROTEINS; VACCINES, DNA;

EID: 0033529512     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(99)00145-0     Document Type: Article

References (32)

1. Stoute J.A., Slaqui M., Heppner G., Momin P., Kester K.E., Desmons P., Wellde B.T., Garcon N., Krzych U., Marchand M., Ballou W.R., Cohen J.D. A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. N Eng J Med. 336:1997;86-91. RTS,S Malaria Vaccine Evaluation Group.
2. Sim B.K.L., Orlandi P.A., Haynes J.D., Klotz F.W., Carter J.M., Camus D., Zegans M.E., Chulay J.D. Primary structure of the 175 K Plasmodium falciparum erythrocyte binding antigen and identification of a peptide which elicits antibodies that inhibit malaria merozoite invasion. J Cell Biol. 111:1990;1877-1884.
3. Chang S.P., Case S.E., Gosnell W.L., Hashimoto A., Kramer K.J., Tam L.Q., Hashiro C.Q., Nikaido C.M., Gibson H.L., Lee-Ng C.T., Barr P.J., Yokota B.T., Hui G.S.N. A recombinant baculovirus 42-kilodalton C-terminal fragment of Plasmodium falciparum Merozoite Surface Protein 1 protects Aotus monkeys against malaria. Infect Immunity. 64:1996;253-261.
4. Kumar S., Yadava A., Keister D.B., Tian J.H., Ohl M., Perdue-Greenfield K.A., Miller L.H., Kaslow D.C. Immunogenicity and in vivo efficacy of recombinant Plasmodium falciparum merozoite surface protein-1 in Aotus monkeys. Mol Med. 1:1995;325-332.
5. Krieg A.M., Yi A-K., Matson S., Waldschmidt T.J., Bishop G.A., Teasdale R., Koretzky G.A., Klinman D.M. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature. 374:1995;546-549.
6. Davis H.L., Weeranta R., Waldschmidt T.J., Tygrett L., Schorr J., Krieg A.M. CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen. J Immunol. 160:1998;870-876.
7. Bird A.P. CpG islands as gene markers in the vertebrate nucleus. Trends Genet. 3:1987;342-347.
8. Krieg A.M., Wu T., Weeratna R., Efler S.M., Love-Homan L., Yang L., Yi A-K., Short D., Davis H.L. Sequence motifs in adenoviral DNA block immune activation by stimulatory CpG motifs. Proc Natl Acad Sci USA. 95:1998;12631-12636.
9. Klinman D., Yi A-K., Beaucage S.L., Conover J., Krieg A.M. CpG motifs expressed by bacterial DNA rapidly induce lymphocytes to secrete IL-6, IL-12, and IFN. Proc Natl Acad Sci USA. 93:1996;2879-2883.
10. Yi A-K., Klinman D.M., Martin T.L., Matson S., Krieg A.M. Rapid immune activation by CpG motifs in bacterial DNA: Systemic induction of IL-6 transcription through an antioxidant sensitive pathway. J Immunol. 157:1996;5394-5402.
11. Yi A.E., Chang M., Peckham D.W., Krieg A.M., Ashman R.F. CpG oligodeoxyribonucleotides rescue mature spleen B cells from spontaneous apoptosis and promote cell cycle entry. J Immunol. 160:1998;5898-5906.
12. Redford T.W., Yi A.K., Ward C.T., Krieg A.M. Cyclosporin A enhances IL-12 production by CpG motifs in bacterial DNA and synthetic oligodeoxynucleotides. J Immunol. 161:1998;3930-3935.
13. Ballas Z.K., Rasmussen W.L., Krieg A.M. Induction of natural killer activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA. J Immunol. 157:1996;1840-1845.
14. Anitescu M., Chace J.H., Tuetken R., Yi A.K., Berg D.J., Krieg A.M., Cowdrey J.S. Interleukin-10 functions in vitro as in vivo to inhibit bacterial DNA-induced secretion of interleukin-12. J Interferon Cytokine Res. 17:1997;781-788.
15. Chace J.H., Hooker N.A., Mildenstein K.L., Krieg A.M., Cowdery J.S. Bacterial DNA-induced NK cell IFN-γ production is dependent on macrophage secretion of IL-12. Clin Immunol Immunopath. 84:1997;185-193.
16. Jakob T., Walker P.S., Krieg A.M., Udey M.C., Vogel J.C. Activation of cutaneous dendritic cells by CpG-containing oligodeoxynucleotides: A role for dendritic cells in the augmentation of Th1 responses by immunostimulatory DNA. J Immunol. 161:1998;3042-3049.
17. Sparwasser T, Koch E-V, Vabulas RM, Heeg K, Lipford GB, Ellwart J, Wagner H, Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells, Eur J Immunol in press;
18. Chu R.S., Targoni O.S., Krieg A.M., Lehmann P.V., Harding C.V. CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity. J Exp Med. 186:1997;1623-1631.
19. Roman M., Martin-Orozco E., Goodman J.S., Nguyen M.D., Sato Y., Ronaghy A., Kornbluth R.S., Richman D.D., Carson D.A., Raz E. Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants. Nature Med. 3:1997;849-854.
20. Lipford G.B., Bauer M., Blank C., Reiter R., Wagner H., Heeg K. CpG-containing synthetic oligonucleotides promote B and cytotoxic T cell responses to protein antigen: a new class of vaccine adjuvants. Eur J Immunol. 27:1997;2340-2344.
21. Moldoveanu Z., Love-Homan L., Huang W.Q., Krieg A.M. CpG DNA, a novel immune enhancer for systemic and mucosal immunization with influenza virus. Vaccine. 16:1998;1216-1224.
22. Klinman D.N., Yamshchikov G., Ishigatsubo Y. Contribution of CpG motifs to the immunogenicity of DNA vaccines. J Immunol. 158:1997;3635-3639.
23. Krieg A.M., Yi A-K., Schorr J., Davis H.L. The role of CpG dinucleotides in DNA vaccines. Trends Microbiol. 6:1998;23-26.
24. Sato Y., Roman M., Tighe H., Lee D., Corr M., Nguyen M.D., Silverman G.J., Lotz M., Carson D.A., Raz E. Immunostimulatory DNA sequences necessary for effective intradermal gene immunization. Science. 273:1996;352-354.
25. Collins W.E. The owl monkey as a model for malaria in Aotus. Baer J.F., Weller R.E., Kakoma I. The Owl Monkey. 1994;Academic Press, San Diego.
26. Gramzinski R.A., Brazolot Millan C.L., Obaldia N., Hoffman S.L., Davis H.L. Immune response to a hepatitis B DNA vaccine in Aotus monkeys: a comparison of vaccine formulation, route, and method of administration. Mol Med. 4:1998;109-118.
27. Weeratna R., Brazolot Millan C.L., Krieg A.M., Davis H.L. Reduction of antigen expression from DNA vaccines by coadministered oligodeoxynucleotides. Antisense Nucleic Acid Drug Dev. 8:1998;351-356.
28. Ma N.S., Rossan R.N., Kelley S.T., Harper J.S., Bedard M.T., Jones T.C. Banding patterns of the chromosomes of two new karyotypes of the owl monkey, Aotus, captured in Panama. J Med Primatol. 7:1978;146-155.
29. Obaldia N. Detection of Klebsiella pneumoniae in Aotus l. lemurinus (Panamanian owl monkey) using an enzyme linked immunosorbant assay (ELISA) test. Lab Anim. 25:1991;133-141.
30. Charoenvit Y., Fallarme V., Rogers W.O., Sacci J.B., Kaur M., Aguiar J.C., Yuan L.F., Corradin G., Andersen E., Wizel B., Houghten R.A., de la Vega P., Hoffman S.L. Development of two monoclonal antibodies against Plasmodium falciparum sporozoite surface protein 2 and mapping of B-cell epitopes. Infect Immunity. 65:1997;3430-3437.
31. Charoenvit Y., Leef M.F., Yuan L.F., Sedegah M., Beaudoin R.L. Characterization of Plasmodium yoelii monoclonal antibodies directed against stage-specific sporozoite antigens. Infect Immunity. 55:1987;604-608.
32. Davis HL, Gene-based vaccines, Adv Gene Delivery in press;